Benitec Biopharma Other 8-K Filing
Benitec Biopharma Inc. has formally engaged Ernst & Young LLP (EY) as its new independent registered public accounting firm for the fiscal year ending June 30, 2027. The engagement follows the completion of EY's client acceptance procedures and the execution of a formal engagement letter on September 29, 2026.
- Counterparty
- Ernst & Young LLP